about
Neuronatin in a subset of glioblastoma multiforme tumor progenitor cells is associated with increased cell proliferation and shorter patient survivalRNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II studyResponse-predictive gene expression profiling of glioma progenitor cells in vitro.Sodium fluorescein-guided resection under the YELLOW 560 nm surgical microscope filter in malignant brain tumor surgery--a feasibility study.Transcranial electro-hyperthermia combined with alkylating chemotherapy in patients with relapsed high-grade gliomas: phase I clinical results.Lactate-modulated induction of THBS-1 activates transforming growth factor (TGF)-beta2 and migration of glioma cells in vitroFluorescein sodium-guided resection of cerebral metastases—experience with the first 30 patients.Fluorescein sodium-guided surgery in cerebral lymphoma.Validation Study: Response-Predictive Gene Expression Profiling of Glioma Progenitor Cells In VitroFluorescein sodium-guided resection of cerebral metastases-an update.Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activationQuantitative Imaging of D-2-Hydroxyglutarate in Selected Histological Tissue Areas by a Novel Bioluminescence Technique.Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2.Metabolic syndrome in relation to risk of meningioma.Early postoperative tumor progression predicts clinical outcome in glioblastoma-implication for clinical trials.Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?Diabetes, use of metformin, and the risk of meningioma.Meningiomas Adjacent to Major Venous Sinuses-Clinical Outcome and Recurrence.Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.Temozolomide preferentially depletes cancer stem cells in glioblastoma.Calcitonin-gene related peptide and cerebral vasospasm.Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies.Recurrence rates and functional outcome after resection of intrinsic intramedullary tumors.Molecular dissection of the valproic acid effects on glioma cells.Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05).Ventriculostomy for acute hydrocephalus in critically ill patients on the ICU--outcome analysis of two different procedures.The influence of intraoperative microelectrode recordings and clinical testing on the location of final stimulation sites in deep brain stimulation for Parkinson's disease.Discrepancies between the MRI- and the electrophysiologically defined subthalamic nucleus.A single neurosurgical center's experience of the resolution of cervical radiculopathy after dorsal foraminotomy and ventral discectomy.Differences in Neuropeptide Y Secretion Between Intracerebral Hemorrhage and Aneurysmal Subarachnoid Hemorrhage.Treatment Of Spontaneous Subarachnoid Hemorrhage And Self-reported Neuropsychological Performance At 6 Months - Results Of A Prospective Clinical Pilot Study On Good-Grade Patients.Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.Multicenter pilot study of radio-chemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).Neuropeptide Y - an early biomarker for cerebral vasospasm after aneurysmal subarachnoid hemorrhage.CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic.Fluorescein sodium in brain tumor surgery - Response.Expression of carbonic anhydrase IX in craniopharyngiomas.Adverse event grading following CTCAE v3.0 underestimates hypertensive side effects in patients with glioma treated with Bevacizumab.Deep brain stimulation in Parkinson's disease: motor effects relative to the MRI-defined STN.
P50
Q28729876-E39C32FE-35F1-4B9A-8BC2-653B58284685Q33499541-21460BDD-F525-49B3-B60A-DC00C0BD7EA2Q34277599-81DE2552-CF59-436B-9D0F-227234633915Q34594708-6E65B120-E72C-4D52-AF8A-ED04BAE7D108Q34615214-4DFABC4D-C282-4CC4-AF0D-C7C0A29F3F5CQ35041092-FA0FEA95-C91B-4F1E-A4F8-B007F572527DQ35590598-0F938FB7-05DF-4FC9-BD8F-1A4634E2B45FQ35798070-50364113-C0D1-4D33-9F4A-F7D3459B54DBQ35957639-529CF2CF-2710-43FA-972F-B2EFA987E79CQ36232692-B8003AE0-EF97-4725-908D-D9FF6B589E06Q36342526-8A7C91B0-7020-4046-A6F4-DD7F84C0B396Q36656510-7CBDF16A-CDB9-45E7-8515-BBA9B4B51B1FQ37118676-4524588D-826A-41AB-98D6-23AA0FFEBECFQ37709266-76ADBD04-DAAE-4938-AE43-E8ABBD2ED384Q37736028-89D12E6C-B3A7-4155-BB2E-1DA6C31C2F63Q38635290-84AC752B-5278-4DFF-BF89-EAEBA336AC1BQ38678835-74BD56E5-12F0-4577-8B5D-819B5F289CADQ38782003-D494E46D-D82E-4B5F-B630-8F02528F1BE6Q39057993-A821076E-6E21-4C68-ADBB-AFF0E074F2E8Q39960750-FB71668F-424F-4376-8E93-28B1E800356FQ40085399-534338CA-0194-49EC-AB6E-811310B0625EQ40105658-A30F3C69-A71D-4DCB-B8C5-D265062C0C78Q40965389-BFFC9C14-1F46-4BBE-B164-06FEBE4B1B8CQ41809551-94FBC57E-D59F-4E12-99EA-44FE7D3DF5B1Q43609687-1198B172-A2ED-49F2-ABCA-214E43E1DF6DQ43811605-07FD0011-9EA0-4E96-8CCD-67BF1F175741Q44764177-0C55A208-819A-459E-AD32-92B9C1FB8433Q45272176-48E6F416-37E3-403B-8293-DCFD46F9EF8DQ45929444-E77B50F3-7751-49AF-B15F-8F110FA8A846Q47290498-9C059ACC-B3FF-45F0-8902-B321A1ECFF07Q47368909-8D777F8A-7C3E-4CE7-8D07-4D7E97A9F1C3Q47614052-AB364D43-6FA0-497A-9F2D-DA8170163D44Q47827397-6998DC31-2034-4390-881A-875CC656F4DEQ47858664-67386471-7E6F-46C4-BC70-597CF03CF171Q48177168-CEAE9B70-FF9D-45FB-9053-5E6CDF6D7835Q48598092-F868B641-8E10-4BAB-B74F-6238A7E60064Q48964684-50963D2E-D937-459D-83CD-01C43299529AQ49044693-B54B426A-47AA-4461-B67F-C6FCD190FF71Q49066603-55E43148-0AFE-430C-AD8F-99A95C2676C2Q50248119-BABBD7A6-ADFB-4512-83E1-D87707E7A9DD
P50
name
Martin Proescholdt
@ast
Martin Proescholdt
@en
Martin Proescholdt
@es
Martin Proescholdt
@nl
type
label
Martin Proescholdt
@ast
Martin Proescholdt
@en
Martin Proescholdt
@es
Martin Proescholdt
@nl
prefLabel
Martin Proescholdt
@ast
Martin Proescholdt
@en
Martin Proescholdt
@es
Martin Proescholdt
@nl